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 37 
Abstract 38 
Background: Invasive urodynamics is used to investigate the causes of lower urinary tract 39 
symptoms; a procedure usually conducted in secondary care by specialist practitioners. No 40 
study has yet investigated the feasibility of carrying out this procedure in a non-specialist 41 
setting. Therefore, the aim of this study was to explore, using qualitative methodology, the 42 
feasibility and acceptability of conducting invasive urodynamic testing in primary care. 43 
Methods: Semi-structured interviews were conducted during the pilot phase of the PriMUS 44 
study, in which men experiencing bothersome lower urinary tract symptoms underwent 45 
invasive urodynamic testing along with a series of simple index tests in a primary care 46 
setting. Interviewees were 25 patients invited to take part in the PriMUS study and 18 47 
healthcare professionals involved in study delivery. Interviews were audio-recorded, 48 
transcribed verbatim and analysed using a framework approach.  49 
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Results: Patients generally found the urodynamic procedure acceptable and valued the 50 
primary care setting due to its increased accessibility and familiarity. Despite some logistical 51 
issues, facilitating invasive urodynamic testing in primary care was also a positive experience 52 
for urodynamic nurses. Initial issues with General Practitioners receiving and utilising the 53 
results of urodynamic testing may have limited the potential benefit to some patients. 54 
Effective approaches to study recruitment included emphasising the benefits of the 55 
urodynamic test and maintaining contact with potential participants by telephone. Patients’ 56 
relationship with their General Practitioner was an important influence on study participation. 57 
Conclusions: Conducting invasive urodynamics in primary care is feasible and acceptable 58 
and has the potential to benefit patients. Facilitating study procedures in a familiar primary 59 
care setting can impact positively on research recruitment. However, it is vital that there is a 60 
support network for urodynamic nurses and expertise available to help interpret urodynamic 61 
results. 62 
Keywords: Urodynamics, primary care, lower urinary tract symptoms, qualitative research 63 
 64 
Background 65 
Lower urinary tract symptoms (LUTS) are highly prevalent amongst men aged over 40, with 66 
over 70% reporting at least one symptom [1], and are associated with reduced emotional 67 
wellbeing, productivity and quality of life [2, 3]. Urodynamics is a  specialist test for 68 
investigating the causes of LUTS [4]. It is typically conducted in secondary care and involves 69 
inserting catheters into the bladder and rectum to enable measurements pertaining to bladder 70 
function. A growing number of patients presenting with LUTS are eventually treated 71 
conservatively and thus could potentially be effectively managed in primary care [5, 6]. 72 
Managing LUTS in primary care  settings could result in benefits for the patient and cost 73 
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benefits for the NHS. However, General Practitioners (GPs) currently do not have access to 74 
simple tools to accurately diagnose the cause of LUTS in men.  75 
 76 
Recognising this issue, the UK National Institute for Health Research (NIHR) released a 77 
Health Technology Assessment (HTA) commissioned call for the development of a clinical 78 
decision aid to help inform treatment choice or need for specialist referral for men presenting 79 
with LUTS in primary care. The PriMUS study (‘Primary care management of lower urinary 80 
tract symptoms in men: development and validation of a diagnostic and clinical decision 81 
support tool’) addresses this brief [7]. PriMUS is a prospective diagnostic accuracy study 82 
based in UK primary care settings. Participants undergo simple index tests together with 83 
invasive urodynamics as a reference standard, to determine the combination of index tests 84 
that best predicts common urodynamic diagnoses. This will inform the development of a 85 
clinical decision support tool for use by GPs with their patients. 86 
 87 
Invasive urodynamics is a complex procedure with risk of adverse effects, yet very few 88 
qualitative studies have explored patient acceptability of this test. One interview study [8] 89 
found patients experienced anxiety and embarrassment about the procedure, which was 90 
alleviated by healthcare professionals through effective interpersonal and communication 91 
skills. Previously, men participating in a randomised controlled trial involving urodynamics 92 
[9] found the procedure acceptable and valued the comprehensive insight into their 93 
symptoms. As healthcare professionals have been found to play an important role in the 94 
patient experience of urodynamics [8, 9],  it is important to further explore their perspectives. 95 
Furthermore, no study has explored in-depth the attitudes of patients who have declined 96 




PriMUS is the first large-scale study to implement invasive urodynamics in a primary care 99 
setting; no study has yet investigated the feasibility and acceptability of conducting this 100 
procedure in a non-specialist setting. This study aimed to explore in-depth the feasibility and 101 
acceptability of providing invasive urodynamics in primary care, including experiences of 102 
recruiting to a urodynamic study, encompassing the perspectives of patients (including those 103 
who declined the procedure) and healthcare professionals. Including these participant groups 104 
provided further insight into attitudes towards and experiences of urodynamics, and the 105 
feasibility of providing urodynamics in primary care, and sought to inform processes or 106 
interventions that could improve acceptability of this invasive procedure. Given the 107 
exploratory nature of the research, a qualitative approach was needed to enable detailed 108 
insight into participant experiences that could not be obtained via quantitative methods such 109 
as questionnaires. The qualitative study was conducted during the pilot phase of the PriMUS 110 
study, so that findings could inform changes to study processes where indicated. 111 
 112 
Methods 113 
Study design 114 
This qualitative study was part of the larger PriMUS study, which gained ethical approval 115 
from Wales Research Ethics Committee 6. PriMUS is recruiting adult men presenting to their 116 
GP with one or more bothersome LUTS, in approximately 90 GP practices across Newcastle 117 
upon Tyne, South Wales and Bristol (see study protocol [7] for full inclusion and exclusion 118 
criteria). Participants to date underwent a series of index tests together with invasive 119 
urodynamics, which is usually carried out in secondary care by specialist practitioners. In the 120 
PriMUS study the procedure was performed by trained research nurses in primary care 121 
settings. Results of the urodynamic procedure and index tests were uploaded to an online 122 
database, quality-checked and reviewed by clinical scientists and urologists on the study team 123 
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(AB, MD, CH and MJD), and a summary of results for GPs was compiled manually. This 124 
included the likely diagnosis(es) and a flowchart of management recommendations based on 125 
National Institute for Health and Care Excellence (NICE) guidelines [10]. 126 
 127 
Before conducting urodynamics as part of the study, research nurses were provided with a 128 
urodynamics manual and underwent a series of training activities to ensure competency, 129 
including completing an accredited urodynamic training course overseen by study urologists, 130 
shadowing urologists in secondary care settings and completing study specific interpretation 131 
and equipment training. They receive frequent, ongoing peer and clinical support from 132 
members of the study management team and have access to a named Urology Champion in 133 
each study region.  134 
 135 
Qualitative methods such as interviews are particularly appropriate to increase understanding 136 
of patient experiences of trial processes [11], and can allow for the exploration of previously 137 
unanticipated issues that may be missed in quantitative studies. Therefore, semi-structured 138 
telephone interviews were conducted with men invited to take part in the main PriMUS 139 
study. Telephone and face-to-face interviews were also carried out with healthcare 140 
professionals involved in study delivery, including GPs and practice nurses involved in study 141 
recruitment, and research nurses who performed the urodynamic procedure. 142 
  143 
Sampling and recruitment 144 
Purposive sampling was used to support maximum variation in terms of study site, decision 145 
to participate in the main PriMUS study (for patients) and role in study delivery (for 146 
healthcare professionals). Patients invited to participate in the main study could indicate 147 
whether they consented to be contacted for a follow-up interview; this included both patients 148 
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who consented to the main study and those who declined to participate. Patients consenting to 149 
be contacted were invited to take part in an interview once they had undergone all study 150 
procedures or had made the decision not to participate in the main PriMUS study. Interview 151 
participants were offered a £10 voucher for their contribution. Healthcare professionals were 152 
approached to take part once they had experience of study processes (e.g. recruiting patients 153 
or performing urodynamics). Recruitment continued until data saturation was reached. 154 
Informed consent (written or verbal) was obtained for all face-to-face and telephone 155 
interviews after participants had sufficient time to read the interview study information sheet. 156 
 157 
Data collection 158 
Semi-structured interview topic guides were developed in consultation with clinicians and 159 
patient representatives on the study team. Topics explored in patient interviews included 160 
thoughts about the main study information, the decision of whether to take part, concerns 161 
about the study, and how others could be encouraged to participate. Those participating in the 162 
main study were also asked about their experience of study processes and specifically the 163 
urodynamic test. Topics covered in healthcare professional interviews included (as 164 
applicable) experiences of study recruitment, perceived patient acceptability of study 165 
processes, staff experiences of performing the urodynamic test, and the feasibility of doing so 166 
in primary care. Topic guides were developed iteratively throughout the data collection 167 
period to allow for the exploration of previously unanticipated themes arising from the 168 
interviews. For example, after issues relating to urodynamic test results were highlighted by 169 
GPs, this was specifically explored in subsequent interviews.  170 
 171 
Interviews were conducted between May 2018 and February 2019. Most were conducted by 172 
SM, an experienced qualitative health researcher, with the remainder conducted by medical 173 
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students (EC, RH and FM) supervised by SM. To encourage respondents to give honest, 174 
unbiased feedback about their experience of the main study, the interviewers were not 175 
previously known to participants and had no involvement in main study procedures. All 176 
interviews were audio-recorded and transcribed verbatim for analysis.  177 
 178 
Analysis 179 
A framework approach [12] was used to analyse interview data. SM compiled a list of key 180 
categories to explore, with reference to the interview topic guide: 1) acceptability of invasive 181 
urodynamics in primary care; 2) feasibility of invasive urodynamics in primary care; and 3) 182 
experiences of recruiting to a urodynamic study. After reading through transcripts, emergent 183 
sub-themes were identified within these three categories in the initial framework. Analysis 184 
was an iterative process, enabling interviews to continue until saturation was reached. 185 
Saturation was determined as being achieved once interviews resulted in no new themes and 186 
when detailed data had been collected relating to each identified theme. SM entered a 187 
framework of categories and sub-themes into NVivo V11 (QSR International), then uploaded 188 
and coded interview transcripts. Ten percent  of transcripts was independently coded by 189 
NJW, and coding was compared and discussed to ensure inter-rater consistency. Sub-themes 190 
were refined throughout the coding process to ensure they captured the diversity of 191 
participants’ experiences. Once all interviews were coded, SM compiled tables to show a 192 
summary of each participant’s responses in relation to each category and sub-theme. Tables 193 
included data extracts from the coded interview transcripts; this enabled the validity of the 194 
proposed themes to be reviewed by SM and NJW, ensuring that there were sufficient data to 195 
support each of the emergent sub-themes, and that they provided an accurate reflection of 196 





Interviews were conducted with 25 male patients and 18 healthcare professionals, from 22 200 
GP practices across Newcastle upon Tyne, South Wales and Bristol (Table 1). Interviews 201 
with patients lasted between 8 and 44 minutes (mean 23.0); interviews with healthcare 202 
professionals lasted between 9 and 30 minutes (mean 18.8). Eight sub-themes were identified 203 
under the three main framework categories: Acceptability of invasive urodynamics in 204 
primary care (three sub-themes), Feasibility of invasive urodynamics in primary care (three 205 
sub-themes) and Recruiting to a urodynamic study (two sub-themes) (see Table 2). 206 
Participant quotes are labelled with a unique participant identification number, with the prefix 207 
MSP for patients who participated in the main study, IP for patients who participated in the 208 
interview element only, GP for General Practitioners and UN for urodynamic nurses.  209 
 210 
  211 
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Table 1 Participant characteristics 212 
 213 
 
Patients (n = 25) 
 
 




































































Table 2 Key framework categories and emergent sub-themes 216 
 217 
Key framework categories Emergent sub-themes 
 
Acceptability of invasive 
urodynamics in primary care 
 
Apprehension and embarrassment 
Communication  
Preference for primary care 
 
Feasibility of invasive urodynamics 
in primary care 
 
Training and support 
Logistical issues 
Difficulties receiving and using results 
 
Recruiting to a urodynamic study 
 
Importance of proactive recruitment 




  220 
 
1 Participant age was not recorded for patients who did not participate in the main PriMUS study.  
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Acceptability of invasive urodynamics in primary care 221 
Apprehension and embarrassment 222 
All patients who underwent urodynamics reported finding the procedure acceptable, with 223 
most finding it as they had expected, or better than expected. Around half reported 224 
discomfort, although this was universally described as brief or mild. Some patients described 225 
feeling apprehensive about the test; those with experience of similar medical procedures (e.g. 226 
cystoscopy) reported lower anxiety. The invasive nature of the procedure was mentioned by 227 
several patients; some commented that this was not an issue for them, while others found it 228 
embarrassing, particularly where the procedure was conducted by female healthcare 229 
professionals. While one suggested this was due to his older age, another explained how he 230 
accepted that getting older meant invasive procedures were more likely (Box 1). 231 
  232 
MSP: Main study participant 233 
 234 
 
BOX 1     Acceptability of invasive urodynamics in primary care 
 
Apprehension and embarrassment: It was a little bit… uncomfortable at first, but I mean 
not greatly so… It was only two seconds… I was a little bit… nervous because I didn’t 
know how painful it was going to be. But it was actually… nothing like what I thought 
it was going to be you know. It was… a lot nicer or better… (MSP 2015, age 65)  
 
She explained it was going to feel a bit uncomfortable when they did it, and it did, it 
tingled a bit but that was about it, it was very much as I expected. (MSP 1023, age 73) 
 
No concerns at all really… I’d had that camera or catheter, or whatever you call it, in 
my bladder twice before. So, I, it didn’t put me off at all. (MSP 3103, age 74) 
 
My biggest problem … I did feel embarrassed with some of the procedure, you know… 
[I’m] old fashioned, that’s the trouble. (MSP 1117, age 84) 
 
If you’re male and you’ve got three women… you know it’s a bit embarrassing… I just 
convinced myself like you’re an old man now, you know, they see these things all the 
time. So I managed to rationalise that… and I realise as I get older you might have to 




A key factor in patient acceptability was the extent to which nurses explained the test, 236 
supported patients with information provision in advance and through the procedure, and 237 
made them feel at ease. Patients reported they had been given the right level of information, 238 
so understood the purpose of the test, and that the nurses made the procedure as comfortable 239 
as possible, which reduced their anxiety. The ‘respectful’ and ‘professional’ manner of nurses 240 
in discussing and conducting urodynamics also helped to reduce patient embarrassment. 241 
 242 
Preference for primary care 243 
Undergoing the urodynamic test in primary rather than secondary care was viewed positively 244 
by patients, mainly due to convenience (e.g. reduced waiting and travel time and ease of 245 
parking) and familiarity with surgery staff. Several patients explained they had ‘full 246 
confidence’ in their GP practice and felt relaxed about visiting the surgery, whilst they would 247 
be more apprehensive if they had to attend hospital for the same procedure (Box 2). Some 248 
suggested that they would not have agreed to undergo urodynamics if the test had been 249 
conducted in hospital.   250 
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MSP: Main study participant  251 
 252 
Feasibility of invasive urodynamics in primary care 253 
Training and support 254 
Urodynamic nurses reported that facilitating urodynamics in primary care was generally a 255 
positive experience. Most had not independently performed invasive urodynamics before 256 
receiving training for the PriMUS study and were apprehensive about conducting the 257 
procedure in a community setting, but all felt their confidence grew as they gained 258 
experience. They valued the initial training and ongoing support provided by the study team, 259 
particularly regular teleconferences with peers and access to ad-hoc telephone advice. 260 
 




They explained everything well… I thought it was quite an uncomfortable test and quite 
deep. But… they were very professional, the way they talked about it and dealt with it… 
they were friendly, they spoke to you during it, you know, you weren’t just like lay 
there… they tried to make you as comfortable as possible. (MSP 2002, age 55) 
 
I found it quite easy, really, with the people I saw, you know, all the way through… That 
was nice not to have to worry about the people… you knew that they were explaining it 
to you and helping you, and guiding you, really. (MSP 3103, age 74) 
 
I was a bit worried at the start… but the girls that did it were, made you feel at ease 
and were brilliant, so I didn’t really feel under any pressure. (MSP 3110, age 56) 
 
Preference for primary care: 
 
I [can’t] see any benefit [to having the test done in hospital], I think it was better at my 
doctors, it was a lot more relaxed, because obviously I knew the nurse and I knew the 
doctor and you know, I had chatted with them about the test. (MSP 2002, age 55)  
 
It saved me going to hospital and… getting a taxi and one thing and another. I think 
that’s more why I did it sort of thing I think at the doctors rather than traipsing round 
the country. (MSP 3110, age 56) 
 







Logistical issues 262 
Several logistical issues related to performing urodynamics in primary care were identified. 263 
Facilities at GP practices varied, and the procedure was sometimes carried out in unsuitable 264 
rooms, for example with a carpeted floor that was difficult to clean, insufficient space or 265 
difficulty accessing a sluice. Remote working meant nurses had to transport heavy equipment 266 
and sometimes experienced internet connectivity issues, which had led to clinic cancellations.  267 
 268 
Difficulties receiving and using results 269 
GPs highlighted problems with receiving and utilising urodynamic results in the initial stages 270 
of the study. Study-specific quality assurance procedures meant GP summaries took longer to 271 
be returned than expected, and where concurrent diagnoses were identified, GPs were unsure 272 
which to treat first. It was suggested this limited the potential benefit of the study to some 273 
patients (Box 3). As GP interviews were conducted in the pilot phase of the PriMUS study, 274 
their feedback enabled changes to be made to site training and the process of obtaining results.  275 
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UN: Urodynamic Nurse; GP: General Practitioner 276 
 277 
Recruiting to a urodynamic study 278 
Importance of proactive recruitment 279 
Main study recruitment was opportunistic or via primary care database searches, with most 280 
GP practices using a combination of these approaches. Healthcare professionals emphasised 281 
 
BOX 3      Feasibility of invasive urodynamics in primary care 
 
Training and support: 
 
It was difficult to begin with and I like being challenged so that was interesting… Being 
able to go to the… urodynamics course was fantastic, that was really, well essential but 
really, really interesting and useful as well and the peer support that we get [from] the 
fortnightly nurse teleconferences [was] particularly useful at the beginning. (UN 506) 
 
We had issues on our very first patient and we were lucky that we’re able to phone up… 
and say what shall we do about this… Having someone on the end of the line is 




[The equipment is] heavy. It’s really bulky. And it’s sensitive equipment as well… It’s 
been hard graft. You’ve got to get it all in the car, get it all out… up hills and over steps 
and in to little rooms. So it’s not good for the equipment. It’s not really good for my 
back [laughs]… It’s quite stressful… making sure I’ve got every single thing to run the 
test. (UN 606) 
 
We don’t always have the most appropriate room available to us in the GP surgeries… 
Sometimes the rooms are tiny, and you literally are falling over each other… sometimes 
the electricity sockets are not in the right place, so we have to use our extension lead… 
there’s lots of sort of improvisation… I think we manage it quite well, but it is a 
challenge. (UN 607) 
 
Difficulties receiving and using results: 
 
You tell [patients that urodynamics] is the gold standard of investigation… And that it 
could help further… define what the problem is, and… target treatment a bit better… 
However… I’ve never had to look at… urodynamics or reports before. And therefore I 
feel what they’re actually getting out of it is… some half-hearted interpretation of… 
what might be the best management plan. So although they may be getting gold standard 























the importance of having a recruitment lead at each practice, to ensure database searches 282 
were carried out regularly and to remind others to recruit opportunistically. Maintaining 283 
telephone contact with patients invited to take part was highlighted as particularly effective in 284 
improving study recruitment and retention.  285 
 286 
Reasons for participation and non-participation 287 
When explaining the study to patients, clinicians emphasised they would have quicker access 288 
to a comprehensive diagnostic test not normally available in primary care, that could help in 289 
the diagnosis and treatment of their LUTS. Accordingly, most patients identified this as a key 290 
factor in their decision to take part. Another common reason for participation was the 291 
altruistic opportunity to contribute to research with the potential to improve medical practice 292 
and benefit others in the future. Some participants specifically desired to raise the profile of 293 
LUTS in men. Others wanted to participate to help their own GP surgery, particularly where 294 
they had built up a good relationship with their GP. Conversely, one patient who declined to 295 
take part in the main study explained he was not familiar with any of the GPs at his surgery. 296 
For patients who opted not to take part in the study, this was mainly because they did not 297 
want to have an invasive test. Those who participated appreciated that the research could be 298 
carried out at a local GP surgery, while those who declined generally mistakenly believed 299 
they would have to attend hospital (Box 4). 300 
 301 
To improve study recruitment, patients suggested clinicians should emphasise that 302 
participants would gain prompt access to a thorough assessment of their symptoms without 303 
needing to go to hospital. Additional reassurance about the urodynamic test was 304 
recommended; for example, explaining that most patients who experience the test find it 305 
acceptable, or giving a detailed timeline of the procedure to show that discomfort associated 306 
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with catheter insertion is short-lived. Other suggestions included advertising the research 307 
more widely, and particularly having the study recommended by a familiar GP. Patients 308 
believed those who were uncomfortable with the thought of the urodynamic test would not 309 
take part in any instance. 310 
UN: Urodynamic Nurse; GP: General Practitioner; MSP: main study participant; IP: 311 
interview-only participant 312 
 313 
 
BOX 4     Recruiting to a urodynamic study 
 
Importance of proactive recruitment: 
 
If you phone [the patient] a day or two beforehand, they’re more likely to come in for 
[their study appointment] … Because, yeah, a couple of people have said, you know if 
you didn’t phone I don’t think I’d be here. (UN 606) 
 
Really you need somebody… leading the recruitment… making sure that that database 
search is done, the list is checked, and the appropriate letter sent out… Which… might 
slip off people’s radar a little bit if it’s not something that’s done regularly. (GP 401) 
 
Reasons for participation and non-participation: 
 
I should benefit from it and so should other people. So to me, even though it was a little 
bit intrusive the test, I still think it was for the right reasons… just the knowledge that 
someone else may benefit from it, makes you feel better. (MSP 2002) 
 
[The doctor] said… the surgery [were] participating in the PriMUS study and would I 
be prepared to take part and I said yes because he’s a fabulous doctor. (MSP 1117) 
 
I said yes, because it was at the surgery, had it… been at the hospital, I would have said 
oh no… you’re talking an hour, an hour and a half one way… but because it was round 
the corner to my house, it was totally different. (MSP 2002) 
 
I don’t like people prodding and poking around my private parts or anything 
[laughs]… I thought no way am I letting them mess around with me… because it’s not 
a very sort of, what shall we say, palatable thing is it really? (IP 301) 
 
I didn’t want [to do anything that] involved having to go to hospital… I would prefer 
not to go to hospital… to do any testing at all… If the GP wanted to do it, yes I don’t 



















To the best of our knowledge, this is the first study to explore the feasibility and acceptability 315 
of invasive urodynamics in primary care, and the first qualitative study of urodynamics to 316 
include the perspectives of primary healthcare professionals. Overall, patients found the 317 
urodynamic test acceptable; a key factor in this was the extent to which nurses made them 318 
feel well-prepared and at ease, highlighting the importance of good communication and the 319 
patient-clinician relationship. Facilitating urodynamics in a primary care setting benefitted 320 
patients, who valued the convenience and familiarity of their GP practice. Urodynamic nurses 321 
also found this to be a positive experience, despite the logistical issues associated with remote 322 
working, and felt well supported by the study team. However, initial issues with receiving 323 
and utilising the results of urodynamic testing may have limited the potential benefit of the 324 
procedure to some patients.  325 
 326 
Approaches found to be effective in recruiting patients to the urodynamic study included 327 
having a recruitment lead at each GP practice, maintaining telephone contact with potential 328 
participants and emphasising to patients that taking part would give them quicker access to a 329 
thorough diagnostic test. Patients’ relationship with their GP was an important influence on 330 
study recruitment; performing invasive urodynamics in primary rather than secondary care 331 
was also a key factor in encouraging participation. Patients suggested additional reassurance 332 
about the procedure would be helpful, particularly for those unsure about taking part. 333 
 334 
The finding that invasive urodynamics is generally acceptable to patients supports 335 
quantitative studies [13, 14], which similarly report that most find the procedure as or better 336 
than expected. As found in previous qualitative research [8, 9], the interpersonal skills of 337 
nurses performing urodynamics, along with good explanation of the procedure, was key to 338 
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patient acceptability. Building on previous work [8], which found that attending hospital to 339 
undergo urodynamics caused anxiety for older patients, we found interview participants 340 
preferred accessing the procedure in primary care. Findings also add to currently limited 341 
research on the effect of clinician-patient relationships on trial recruitment; as found in 342 
questionnaire studies [15, 16], patients’ familiarity with their GP appeared to influence their 343 
decision to participate.  344 
 345 
This study provides an in-depth exploration of an under-researched area, adding new insights 346 
into patients’ acceptance of an invasive procedure in primary care. A key strength is our large 347 
and diverse sample, including the perspectives of primary healthcare professionals which 348 
have not previously been explored. Although we interviewed men across several 349 
geographical areas and of a wide range of ages, most were aged over 50. Therefore, findings 350 
may not be generalisable to younger men, who may experience urodynamic testing 351 
differently [17, 18]. Furthermore, we only interviewed three men who declined to take part in 352 
the urodynamic study due to difficulties recruiting participants from this group, so were 353 
unable to explore reasons for non-participation in detail. Some interviews were brief, 354 
dependent on the extent of participants’ involvement in the main PriMUS study; however the 355 
research aims were highly focused and specific, enabling full examination of the research 356 
issue. Although our overall sample size is comparable to that obtained in similar qualitative 357 
studies (e.g. UPSTREAM [9]), a larger quantitative study based on this exploratory work 358 
would be useful to confirm findings. All interviewers were female, and none were qualified 359 
healthcare professionals, which may have affected the extent to which male patients were 360 
willing to discuss their experiences of urodynamic testing. However, interview participants 361 




Study findings indicate several recommendations for future research and practice. Facilitating 364 
study procedures where possible in local primary care settings can result in increased 365 
participation rates and reduced anxiety for patients, particularly where the invitation to 366 
participate is from a familiar GP. More widely, conducting invasive urodynamics in primary 367 
care may encourage greater uptake of the procedure and reduce the need for hospital referral. 368 
Findings may also apply more widely to conducting urodynamics in community settings. If 369 
implementing this in practice, it would be important to ensure nurses performing 370 
urodynamics are comprehensively trained and have access to specialist advice. Having an 371 
experienced clinician to interpret urodynamic results and provide a clear, timely summary for 372 
GPs and patients is vital to ensure patients benefit fully from the invasive test. Dedicated 373 
space for urodynamics in a community hub setting would help overcome the logistical 374 
difficulties of transporting equipment and working in clinics with varying facilities. Due to 375 
the invasive nature of the urodynamic test, patients may benefit from additional reassurance 376 
(e.g. via telephone) prior to the procedure.  377 
 378 
Future research could further explore the effects on study recruitment of performing research 379 
procedures in primary vs. secondary care settings, and of patients being invited to participate 380 
by their own GP vs. other healthcare professionals. Greater exploration of the perspectives of 381 
patients who decline invasive urodynamics would provide a more rounded insight into 382 
acceptability of the procedure. Including the views of urodynamic nurses with a greater range 383 
of experience would also allow more in-depth exploration of the feasibility of conducting 384 





Findings indicate that conducting invasive urodynamics in primary care is feasible and 388 
acceptable to patients and healthcare professionals and may encourage uptake of the 389 
procedure. Facilitating study procedures in familiar primary care settings can also impact 390 
positively on research recruitment. Expertise to help interpret urodynamic results, together 391 
with a support network for urodynamic nurses working remotely, is essential to ensure the 392 
potential benefits of the test are realised. 393 
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